Vision Research has had a long and illustrious history at Yale. From the observations of Retinal Pigment Epithelium transdifferentiation in the 1950's, through the preclinical development of Timolol in the 1970's, the identification of cyclic GMP as an important photoreceptor messenger in the 1970's, to the identification of a gene for Macular Degeneration in 2005, Yale scientists have always been at the forefront of vision research.

It remains our mission to be a center of excellence and to carry out groundbreaking research on the development, structure and function of the visual system. We also take very seriously our obligation to translate these research findings into new treaments that can benefit those suffering from blinding eye diseases. In addition we provide a rigorous training environment for graduate students and postdoctoral fellows and a serve as a center for a wide range of international collaborations.

Vision Research has had a long and illustrious history at Yale. From the observations of Retinal Pigment Epithelium transdifferentiation in the 1950's, through the preclinical development of Timolol in the 1970's, the identification of cyclic GMP as an important photoreceptor messenger in the 1970's, to the identification of a gene for Macular Degeneration in 2005, Yale scientists have always been at the forefront of vision research.

It remains our mission to be a center of excellence and to carry out groundbreaking research on the development, structure and function of the visual system. We also take very seriously our obligation to translate these research findings into new treaments that can benefit those suffering from blinding eye diseases. In addition we provide a rigorous training environment for graduate students and postdoctoral fellows and a serve as a center for a wide range of international collaborations.

Macular Degeneration Center at Yale

  Primary   Faculty  

  Secondary And Visiting Faculty  

  Drug   Development